Address
Email address
Phone number
Magades nooreks- Yaluronica hüaluroonhappe ja nutika mikrokiuga riietusTutvu tootevalikugaToidulisandidTutvu tootevalikuga RavisukadTutvu tootevalikuga Ravisukad retseptigaTutvu tootevalikuga Reisi- ja sporditootedTutvu tootevalikuga TugisukadTutvu tootevalikugaElastiksidemedTutvu tootevalikuga AntitromboosisukadTutvu tootevalikugaDiabeedisokidTutvu tootevalikuga OrtoosidTutvu tootevalikuga Emakasisesed vahendid Tutvu tootevalikugaLapsesugu määrav testTutvu tootevalikuga Muud tootedTutvu tootevalikuga
Name
Brecuro Medical OÜ
Registry code
11999260
VAT number
EE101398556
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.09.2010 (14)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
46462 - Wholesale of medical appliances and surgical and orthopaedic instruments and devices
101 936 €
6 032 €
6%
-
47 088 €
0
Submitted
No tax arrears
13%
10%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Galina Aru 01.05.1970 (54) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
2019 25.06.2020 | 2020 30.06.2021 | 2021 07.07.2022 | 2022 30.06.2023 | 2023 28.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 73 203 € | 99 219 € | 72 158 € | 92 721 € | 101 936 € |
Net profit (loss) for the period | 10 058 € | 22 196 € | -6 293 € | 2 830 € | 6 032 € |
Profit Margin | 14% | 22% | -9% | 3% | 6% |
Current Assets | 30 318 € | 51 321 € | 48 517 € | 44 618 € | 59 216 € |
Fixed Assets | - | - | - | - | - |
Total Assets | 30 318 € | 51 321 € | 48 517 € | 44 618 € | 59 216 € |
Current Liabilities | 8 542 € | 7 349 € | 10 838 € | 3 562 € | 12 128 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 21 776 € | 43 972 € | 37 679 € | 41 056 € | 47 088 € |
Employees | 0 | 0 | 0 | 0 | 0 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 22 303.21 € | 5 342.58 € | 3 499.13 € | - |
2023 Q4 | 20 902.48 € | 3 826.25 € | 2 747.9 € | - |
2023 Q3 | 19 112.91 € | 2 853.56 € | 1 759.76 € | - |
2023 Q2 | 19 738.32 € | 3 213.93 € | 2 639.64 € | - |
2023 Q1 | 41 910.98 € | 5 094.16 € | 2 286.55 € | - |
2022 Q4 | 19 533.77 € | 3 755.39 € | 2 717.94 € | - |
2022 Q3 | 28 809.61 € | 3 808.06 € | 2 717.94 € | - |
2022 Q2 | 22 268.49 € | 2 522.15 € | 1 580.37 € | - |
2022 Q1 | 30 900.15 € | 2 682.88 € | 1 580.37 € | - |
2021 Q4 | 25 348.38 € | 2 847.57 € | 1 580.37 € | - |
2021 Q3 | 23 431.24 € | 3 047.93 € | 1 580.37 € | - |
2021 Q2 | 28 723.02 € | 3 632.03 € | 1 580.37 € | - |
2021 Q1 | 32 917.25 € | 4 010.84 € | 1 580.37 € | 1 |
2020 Q4 | 41 993.05 € | 3 642.71 € | 1 580.37 € | 1 |
2020 Q3 | 39 018.16 € | 3 197.16 € | 1 580.37 € | 1 |
2020 Q2 | 21 784.15 € | 1 401.69 € | - | 1 |
2020 Q1 | 33 483.62 € | 4 041.9 € | 1 579.84 € | 1 |